# The Use of Monodisperse Poly(propylene glycol)‑8 as a Polymeric Additive: Effect on the Gelation Temperature and Rheological Properties of Pluronic Hydrogels

**Authors:** Zuzanna Samol, Erik Agner, Magne O Sydnes

PMC · DOI: 10.1021/acsomega.5c02773 · 2025-07-28

## TL;DR

This study shows how adding a specific polymer, PPG-8, improves the properties of Pluronic F127 hydrogels for better medical use.

## Contribution

The use of monodisperse PPG-8 as a cost-effective modifier to enhance Pluronic hydrogel properties is novel.

## Key findings

- Adding PPG-8 increased the gelation temperature of Pluronic F127 from 21 to 31 °C.
- PPG-8 increased the release of hydrophobic molecules from 20% to 60%.
- PPG-8 reduced the initial burst release of hydrophilic molecules from 81% to 56%.

## Abstract

Pluronic F127 is widely used for hydrogel preparation,
but its
low gelation temperature (21 °C at a concentration of 25 wt %)
and limited ability to deliver hydrophobic drugs hinder medical applications.
A standard approach to address these limitations involves combining
Pluronic F127 with other polydisperse polymers, further increasing
the system complexity. This study demonstrates the use of monodisperse
and high-purity poly­(propylene glycol)-8 (PPG-8), obtained via cost-effective
chromatographic purification, as a polymeric modifier. The effect
of PPG-8 addition to Pluronic F127, varying from 5 to 20 parts (w/w),
was assessed via the vial tilt method and oscillatory rheology. The
incorporation of PPG-8 increased the gelation temperature from 21
to 31 °C. The impact of PPG-8 addition on the release of small
hydrophilic and hydrophobic molecules was also studied. In the presence
of PPG-8, the cumulative release of a hydrophobic small molecule increased
from 20% to 60%. Contrastingly, the initial burst release of a small
hydrophilic molecule was reduced from 81% to 56% in the first 10 min.
These findings showcase the use of high-purity modifiers such as PPG-8
to fine-tune the properties of Pluronic hydrogels, enabling more reproducible
formulations for potential clinical use.

## Linked entities

- **Chemicals:** Pluronic F127 (PubChem CID 24751)

## Full-text entities

- **Diseases:** toxicity (MESH:D064420)
- **Chemicals:** ibuprofen (MESH:D007052), PPG (MESH:C012504), -8 (-), PEG (MESH:D011092), curcumin (MESH:D003474), lidocaine (MESH:D008012), NVA (MESH:C040937), trifluoroacetic acid (MESH:D014269), T (MESH:D014316), propylene glycol (MESH:D019946), bupivacaine hydrochloride (MESH:D002045), Pluronic (MESH:D020442), water (MESH:D014867), rutin (MESH:D012431), methanol (MESH:D000432), polymer (MESH:D011108), PBS (MESH:D007854), PPG15 (MESH:C451730), emodin (MESH:D004642), PEG400 (MESH:C000595213), chitosan (MESH:D048271), acetonitrile (MESH:C032159), hyaluronic acid (MESH:D006820)
- **Mutations:** C with 20, C with 0, F127, C in 1, F127 G

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12355303/full.md

---
Source: https://tomesphere.com/paper/PMC12355303